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Abstract: Prader-Willi Syndrome (PWS) is a neurodevelopmental disorder caused by loss of
expression of the paternally inherited genes on chromosome 15q11.2-q13. However, the core
features of PWS have been attributed to a critical interval (PWS-cr) within the 15q11.2-q13 imprinted
gene cluster, containing the small nucleolar RNA (snoRNA) SNORD116 and non-coding RNA IPW
(Imprinted in Prader-Willi) exons. SNORD116 affects the transcription profile of hundreds of genes,
possibly via DNA methylation or post-transcriptional modification, although the exact mechanism
is not completely clear. IPW on the other hand has been shown to specifically modulate histone
methylation of a separate imprinted locus, the DLK1-DIO3 cluster, which itself is associated with
several neurodevelopmental disorders with similarities to PWS. Here we review what is currently
known of the molecular targets of SNORD116 and IPW and begin to disentangle their roles in
contributing to the Prader-Willi Syndrome phenotype.
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1. Introduction
Prader-Willi Syndrome (PWS) is a neurodevelopmental disorder characterized by hypotonia and
slow growth rate in infancy, followed by severe hyperphagia throughout childhood and adulthood,
often leading to obesity and associated problems. Individuals with PWS also exhibit mild to moderate
learning disability and, in rare cases, psychosis and other psychiatric conditions [1]. Prader-Willi
Syndrome is caused by loss of function mutations affecting the expression of genes on chromosome
15q11.2-q13. The genes in this cluster are imprinted, meaning that they are expressed only from one
parental copy of the chromosome, and suppressed on the other. The imprinting of the Prader-Willi
gene cluster is established during embryogenesis by a differentially methylated CpG island at the
5’ end of the bicistronic SNURF-SNRPN gene [2,3]. This CpG island is known as the imprinting
center of the locus [4,5]. On the maternally inherited chromosome, the DNA in the imprinted center is
methylated, which leads to the recruitment acetylation and methylation chromatin marks that repress
the transcription of maternal PWS genes.
The 15q11.2-q13 region contains some paternally expressed genes, including five protein-coding
genes (MKRN3, MAGEL2, NECDIN, SNURF-SNRPN), a cluster of small nucleolar RNAs (snoRNAs),
and the non-coding RNA IPW (Figure 1). The PWS imprinted gene cluster also includes two maternally
expressed protein coding genes (UBE3A and ATP10A) [6]. Loss of expression of paternally inherited
genes leads to Prader-Willi syndrome, while the loss of expression of maternally inherted genes, and
UBE3A in particular, leads to a distinct neurodevelopmental disorder—Angelman syndrome [7].
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Figure 1. Simplified schematic of the Prader-Willi syndrome locus. (A) 15q11.2-q13 imprinted region 
contains five paternally expressed protein-coding genes and a cluster of paternally expressed non-
coding RNAs. The locus also includes two maternally expressed protein-coding genes. The 
imprinting of the locus is established by DNA methylation of a regulatory region upstream of the 
paternally expressed SNURF-SNRPN allele, which is known as the imprinting center; and (B) The 
non-coding RNAs in the PWS locus contain five clusters of small nucleolar RNAs (snoRNAs) and the 
Imprinted in Prader Willi (IPW) exons. The SNORD116 cluster together with IPW form the PWS-cr 
interval. 
The non-coding RNAs of the PWS cluster play an important role in the Prader-Willi syndrome 
phenotype by regulating the expression of other genes in a combination of epigenetic and post-
transcriptional processes [8–10]. In particular, the Prader-Willi critical region (PWS-cr), containing 
the SNORD116 cluster and IPW, has been shown to contribute heavily to some of the symptoms of 
PWS, including the hyperphagia, metabolism, and some anxiety-related behaviors. This review aims 
to elucidate the current knowledge of the molecular targets of SNORD116 and IPW and how their 
regulatory role affects the Prader-Willi syndrome phenotype. 
2. Functional Consequences of Prader-Willi Syndrome (PWS)-Critical Interval Deletion 
The PWS-cr interval is thought to be responsible for the majority of the symptoms associated 
with PWS, since deletion of the PWS-cr alone has been found sufficient to induce the core PWS 
phenotype [11]. Due to the high (but not complete) levels of conservation of the PWS cluster between 
humans and mice, mouse models have become an invaluable tool for studying the physiological and 
behavioral phenotypes associated with the syndrome. The knock-out of the PWS-cr interval in mice 
leads to a low birth weight and failure to grow in the first few weeks of life, which is comparable to 
the phenotype observed in humans [12–15]. Furthermore, some studies on PWS-cr deficient mice 
have demonstrated a replication of hyperphagia [15,16], although this behavior does not lead to 
obesity in these models. However, it has to be noted that other studies on this mouse model have 
shown no differences in the feeding behavior of mutants compared to wild type [17,18], leaving the 
link between the PWS-cr interval and hyperphagia in contention. 
Additionally, loss of gene expression from the PWS-cr interval has been associated with a 
number of other phenotypes. These include disruption of circadian rhythms both in patients and 
mouse models, which manifest as an alteration in sleep patterns and specifically REM and Non-REM 
cycles, as well as a disturbance in metabolism, thermogenesis and food anticipation activity [14,19]. 
Due to the entanglement of the circadian clock with numerous physiological functions, it is possible 
that the disruption of these rhythms is at the base of a multitude of the symptoms associated with 
Prader-Willi syndrome [20–22]. 
Figure 1. Simplified schematic of the Prader-Willi syndrome locus. (A) 15q11.2-q13 imprinted
region contains five paternally expressed protein-coding genes and a cluster of paternally
expressed non-coding RNAs. The locus also includes two maternally expressed protein-coding
genes. The imprinting of the locus is established by DNA methylation of a regulatory region
upstream of the paternally expressed SNURF-SNRPN allele, which is known as the imprinting
center; and (B) The non-coding RNAs in the PWS locus contain five clusters of small nucleolar RNAs
(snoRNAs) and the Imprinted in Prader Willi (IPW) exons. The SNORD116 cluster together with IPW
form the PWS-cr interval.
The non-coding RNAs of the PWS cluster play an important role in the Prader-Willi syndrome
phenotype by regulating the expression of other genes in a combination of epigenetic and
post-transcriptional processes [8–10]. In particular, the Prader-Willi critical region (PWS-cr), containing
the SNORD116 cluster and IPW, has been shown to contribute heavily to some of the symptoms of
PWS, including the hyperphagia, metabolism, and some anxiety-related behaviors. This review aims to
elucidate the current knowledge of the molecular targets of SNORD116 and IPW and how their
regulatory role affects the Prader-Willi syndrome phenotype.
2. Functional Consequences of Prader-Willi Syndrome (PWS)-Critical Interval Deletion
The PWS-cr interval is thought to be responsible for the majority of the symptoms associated
with PWS, since deletion of the PWS-cr alone has been found sufficient to induce the core PWS
phenotype [11]. Due to the high (but not complete) levels of conservation of the PWS cluster between
humans and mice, mouse models have become an invaluable tool for studying the physiological and
behavioral phenotypes associated with the syndrome. The knock-out of the PWS-cr interval in mice
leads to a low birth weight and failure to grow in the first few weeks of life, which is comparable to
the phenotype observed in humans [12–15]. Furthermore, some studies on PWS-cr deficient mice have
demonstrated a replication of hyperphagia [15,16], although this behavior does not lead to obesity in
these models. However, it has to be noted that other studies on this mouse model have shown no
differences in the feeding behavior of mutants compared to wild type [17,18], leaving the link between
the PWS-cr interval and hyperphagia in contention.
Additionally, loss of gene expression from the PWS-cr interval has been associated with
a number of other phenotypes. These include disruption of circadian rhythms both in patients and
mouse models, which manifest as an alteration in sleep patterns and specifically REM and Non-REM
cycles, as well as a disturbance in metabolism, thermogenesis and food anticipation activity [14,19].
Due to the entanglement of the circadian clock with numerous physiological functions, it is possible
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that the disruption of these rhythms is at the base of a multitude of the symptoms associated with
Prader-Willi syndrome [20–22].
However, some have questioned whether patients carrying a minimal deletion affecting the
PWS-cr present with true PWS [23]. For instance, there is little evidence linking the deletion of the
PWS-cr interval with the behavioral and cognitive features characteristic in PWS, although the PWS-cr
interval has also been associated with anxiety and some learning disabilities [11,16,24]. Nevertheless,
it still remains that deletion of the PWS-cr alone is sufficient to cause the core physiological features of
PWS [11] and given this, it is critical that we examine the role of the genes within this interval.
3. SNORD116
The SNORD116 locus contains a cluster of thirty or more snoRNAs, belonging to one of the two
repetitive clusters of snoRNAs in the mammalian genome [25]. All of the 15q11.2-q13 PWS region
snoRNAs (SNORD64, SNORD107, SNORD109, SNORD115, SNORD116) are classified as “C/D box
snoRNAs”. The C and D boxes are short conserved sequence elements, which allow snoRNAs to
regulate site-specific methylation of ribosomal RNA (rRNA) [26]. This process is essential for the
maintenance of proper ribosomal function, since it is thought to affect the maturity and stability of
rRNA. However, none of the C/D box snoRNAs of the PWS region have a direct rRNA target [27],
and studies of their functional role have given contradictory results.
Of the snoRNA clusters in the PWS locus, SNORD115 is the only one that has a clear target.
SNORD115 has been demonstrated to affect the alternative splicing and A-to-I editing of the
2C serotonin receptor pre-RNA [28], which has been associated with hyperphagia and eating
abnormalities, as well as with psychiatric disorders [29–31]. The exact mechanisms behind this
regulatory effect are unknown. Interestingly, two of the snoRNAs within the SNORD116 cluster,
have been shown to associate with FOX2 from the FOX family, which is a known regulator of
splicing [32]. These snoRNAs are left untrimmed from long non-coding RNAs (lncRNAs) found
between them, and bind FOX2 in a sno-lncRNA formation [17,32]. However, a recent analysis of
hypothalamic transcripts indicated no differences in alternative splicing between PWS-cr deficient
mice and wild type [15].
Currently, little is known about the direct molecular target(s) of SNORD116. The recognition
sites of SNORD116 are not complementary to any known rRNA, tRNA or snRNA sequence. However,
the SNORD116 cluster has been demonstrated to affect the expression levels of multiple genes.
A study by Falaleeva et al. [33] on HEK 293T cells and post-mortem hypothalamus cells of PWS
patients demonstrated that SNORD116 affects the transcription of over 200 genes. This activity
was shown to be modified by SNORD115, suggesting a synergetic relationship between the two
snoRNAs. Falaleeva et al. [33] hypothesize that SNORD115 and SNORD116 might form heterodimers,
which is compliant with a previously proposed model of C/D box snoRNAs forming dimers [34].
Other RNA-sequencing and microarray studies have also shown that in the absence of the SNORD116
cluster, the expression of genes that play a role in feeding, skeletal development and circadian rhythm
pathways are altered [15,17].
Recently, the SNORD116 cluster was also shown to potentially affect gene expression through
rhythmic DNA methylation [35]. As previously mentioned, the PWS-cr interval has been associated
with the regulation of circadian rhythms. This particular role of the interval has been attributed
mostly to SNORD116, since the snoRNAs of the cluster are predominantly expressed in the
neuropeptide Y neurons of the hypothalamus, which is where the “master” circadian molecular
clock is located [15,19]. Coulson et al. [35] suggested that the SNORD116 cluster is involved in the
regulation of diurnal rhythm of DNA methylation in the mouse cortex. Using whole genome bisulfite
sequencing at six different time points, they demonstrated that over 23,000 CpG sites are methylated
rhythmically, and that this rhythm is disrupted in the PWS-cr+/− mice. The dysregulated genes are
reportedly enriched for body mass index, cholesterol and diurnal metabolism phenotypes, which are
all associated with obesity and could be playing a part in the PWS phenotype.
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One of the suggested mechanisms via which the SNORD116 cluster might regulate rhythmic
DNA methylation is through long-noncoding RNAs (lncRNAs) flanking the copies of the SNORD116
snoRNAs. These lncRNAs are spliced to form an RNA cloud, which associates with transcription
factor RBBP5 and regulates the expression of circadian genes CLOCK, CRY1 and PER2. This synergetic
relationship between the SNORD116 snoRNAs and their flanking lncRNAs is thought to occur
independently of the sno-lncRNA-FOX2 mechanism, which might be involved in assisting alternative
splicing [17].
Another possible pathway for SNORD116 mediated regulation of circadian rhythms is through
A-to-I editing of methylation sites. One of the main enzymes behind A-to-I editing known as
adenosine-deaminase-acting-on-RNA (ADAR2), is thought to be mediated by C/D box snoRNAs [36],
with SNORD115 being a prime example of one of those snoRNAs [9,28]. ADAR2 was also recently
shown to regulate the circadian clocks by performing rhythmic A-to-I editing [37]. Furthermore,
elimination of circadian rhythms in mice has been associated with lower weight and less subcutaneous
fat [38], which is similar to one of the phenotypes observed in PWS-cr+/− mice. However, there is
no body of evidence to support this hypothesis, and although SNORD116 is now known for playing
an essential role in the PWS phenotype, its exact molecular target still remains unclear and requires
further studies.
4. Imprinted in Prader-Willi (IPW)
All patients carrying a mutation of the SNORD116 cluster harbor a deletion that spans the
non-coding Imprinted in Prader-Willi (IPW) gene as well [11]. Similarly, the deletion of Snord116 in
existing mouse models also affects the Ipw gene. Consequently, teasing apart the roles played by the
Snord116 cluster and Ipw remains a key issue in understanding the neural basis of the PWS phenotype.
The molecular function of IPW was unknown until a recent study of a stem cell model of PWS
showed that one of the roles of the RNA is to suppress the transcription of another cluster of imprinted
genes, namely the DLK1-DIO3 locus, located on chromosome 14 (Figure 2A) [8]. The proposed
mechanism for this regulation suggests that IPW is reponsible for the maintenance of repressive
chromatin marks at this locus, which lowers expression of the maternally expressed genes (MEGs)
in the DLK1-DIO3 region, and is suggestive of wider imprinted gene network [39]. Specfifically,
Stelzer et al. [8] demonstrated that IPW interacts with G9A histone methyltransferase, which is
capable of catalyzing lysine 9 histone H3 tri-methylation (H3K9me3) (Figure 2B). Pluripotent stem
cells from PWS patients (PWS-iPSCs) were shown to exhibit significantly decreased levels of H3K9me3
at a region which controls the expression of the MEGs at the DLK1-DIO3 cluster. This phenotype is
fully rescued by the re-introduction of IPW into the PWS-iPSCs [8], which suggests that deletion of
IPW leads to overexpression of the MEGs in the locus.
Interestingly, very recently Coulson et al. [35] demonstrated that the maternally expressed
genes of the DLK1-DIO3 locus lose diurnal DNA methylation marks in the absence of PWS-cr in
mice, and hypothesized that this process is disrupted by the absence of the SNORD116 cluster. Current
evidence of the role of the PWS-cr interval is suggestive of a synergetic relationship between IPW and
SNORD116, which act together to regulate the expression of the DLK1-DIO3 locus MEGs through
histone and DNA methylation, respectively.
Role of the DLK1-DIO3 Locus
Although the phenotypic function of IPW has not been explored experimentally, the effects of
some of the genes in the DLK1-DIO3 locus have been studied extensively. The DLK1-DIO3 imprinted
locus contains three paternally expressed protein-coding genes (DLK1, RTL1, DIO3) and multiple
maternally expressed non-coding genes, including C/D box snoRNAs and micro-RNAs (miRNAs)
(Figure 2A) [40,41]. The maternally expressed miRNAs (miR-379/miR-410) in the DLK1-DIO3 cluster
are of particular importance for the understanding of the PWS phenotype and how it might be affected
by IPW’s regulatory role. The DLK1-DIO3 miRNAs are known to target over 400 genes, which are
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collectively associated with 67 human diseases, including various physiological anomalies and learning
disabilities [42].
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Figure 2. Schematic of how IPW down-regulates the expression of maternally expressed genes in the 
DLK1-DIO3 locus. (A) The DLK1-DIO3 locus contains three paternally expressed protein coding 
genes, and multiple maternally expressed non-coding genes (MEGs); and (B) IPW downregulates the 
expression of the MEGs by recruiting G9A histone methyltransferase, which adds repressive methyl 
groups on lysine 9 of the amino acid tail of H3, of the nucleosomes around which the DLK1-DIO3 
MEGs are wrapped. 
Deletion of the miR-379/miR-410 cluster in mouse models leads to increased anxiogenic behavior, 
as well as with disturbances in metabolic control and homeostasis maintenance [42,43]. These 
phenotypic outcomes are comparable with the physiological and behavioral phenotypes observed in 
patients and mouse models carrying a deletion of the PWS-cr interval [8,11,16,24]. Furthermore, 
overexpression of the MEGs at the DLK1-DIO3 locus is known to cause Temple syndrome, which is 
also characterized by symptoms similar to PWS, most notably the early-age hypotonia [44]. The 
phenotypic overlap between a DLK1-DIO3 MEGs and the PWS-cr interval suggests that some of the 
core features of Prader-Willi syndrome may be caused by dysregulation of the maternal genes on the 
DLK1-DIO3 locus, rather than directly by (or, more likely, in addition to) the genes in the PWS locus. 
Interestingly, the DLK1-DIO3 and PWS gene clusters encode the only two regions of repetitive 
snoRNAs in the mammalian genome. Similar to the PWS locus, the DLK1-DIO3 C/D box snoRNAs 
also lack well defined rRNA targets and have a very similar genomic organization to the SNORDs of 
the PWS locus [45,46]. These parallels have instigated the hypothesis that perhaps the two imprinted 
clusters may have been derived from a common ancestor during mammalian evolution [45], which 
offers another explanation for the similarities in the phenotypes associated with the DLK1-DIO3 and 
the PWS-cr interval loci. 
5. Conclusions 
Although generally caused by loss of paternal gene expression from 15q11-q13, the core of 
characteristics of Prader-Willi syndrome have been pinpointed to the PWS-cr interval containing the 
SNORD116 snoRNA and IPW exons. Deletion of the PWS-critical region affects the expression of 
hundreds of genes via a number of putative mechanisms, and to cause many of the symptoms 
associated with PWS. Furthermore, recent studies link the PWS-cr interval with the regulation of a 
distinct imprinted cluster, namely the DLK1-DIO3 imprinted locus through DNA and histone 
methylation. Since loss of expression from the maternal genes located in DLK1-DIO3 is also associated 
with aspects of the features typical of PWS, these novel discoveries have added a new layer of 
complexity to our current understanding of the molecular mechanisms behind this syndrome. 
Teasing apart the potential effects of SNORD116, IPW and the DLK1-DIO3 maternally expressed 
genes would inform not only our understanding of Prader-Willi syndrome, but also of multiple other 
pathways related to metabolical, circadian and cognitive health problems. 
Figure 2. Schematic of how IPW down-regulates the expression of maternally expressed genes in
the DLK1-DIO3 locus. (A) The DLK1-DIO3 locus contains three paternally expressed protein coding
genes, and multiple maternally expressed non-coding genes (MEGs); and (B) IPW downregulates the
expression of the MEGs by recruiting G9A histone methyltransferase, which adds repressive methyl
groups on lysine 9 of the amino acid tail of H3, of the nucleosomes around which the DLK1-DIO3
MEGs are wrapped.
Deletion of the miR-379/miR-410 cluster in mouse models leads to increased anxiogenic
behavior, as well as with disturbances in metabolic control and homeostasis maintenance [42,43].
These phenotypic outcomes are comparable with the physiological and behavioral phenotypes
observed in patients and mouse models carrying a deletion of the PWS-cr interval [8,11,16,24].
Furthermore, overexpression of the MEGs at the DLK1-DIO3 locus is known to cause Temple syndrome,
which is also characterized by symptoms similar to PWS, most notably the early-age hypotonia [44].
The phenotypic overlap between a DLK1-DIO3 MEGs and the PWS-cr interval suggests that some of
the core features of Prader-Willi syndrome may be caused by dysregulation of the maternal genes on
the DLK1-DIO3 locus, rather than directly by (or, more likely, in addition to) the genes in the PWS locus.
Interestingly, the DLK1-DIO3 and PWS gene clusters encode the only two regions of repetitive
snoRNAs in the mammalian genome. Similar to the PWS locus, the DLK1-DIO3 C/D box snoRNAs
also lack well defined rRNA targets and have a very similar genomic organization to the SNORDs of
the PWS locus [45,46]. These parallels have instigated the hypothesis that perhaps the two imprinted
clusters may have been derived from a common ancestor during mammalian evolution [45], which
offers another explanation for the similarities in the phenotypes associated with the DLK1-DIO3 and
the PWS-cr interval loci.
5. Conclusions
Although generally caused by loss of paternal gene expression from 15q11-q13, the core of
characteristics of Prader-Willi syndrome have been pinpointed to the PWS-cr interval containing the
SNORD116 snoRNA and IPW exons. Deletion of the PWS-critical region affects the expression of
hundreds of genes via a number of putative mechanisms, and to cause many of the symptoms
associated with PWS. Furthermore, recent studies link the PWS-cr interval with the regulation of
a distinct imprinted cluster, namely the DLK1-DIO3 imprinted locus through DNA and histone
methylation. Since loss of expression from the maternal genes located in DLK1-DIO3 is also associated
with aspects of the features typical of PWS, these novel discoveries have added a new layer of
complexity to our current understanding of the molecular mechanisms behind this syndrome. Teasing
apart the potential effects of SNORD116, IPW and the DLK1-DIO3 maternally expressed genes would
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inform not only our understanding of Prader-Willi syndrome, but also of multiple other pathways
related to metabolical, circadian and cognitive health problems.
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